SCHEMBL4896077

SCHEMBL4896077

O=C(NNC(=S)NC(Cc1ccccc1)CN1C(=O)c2ccccc2C1=O)c1ccc2cnccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.41
ALDH1A1 P00352 4/20 0.40
TSHR P16473 1/20 0.40
CDK2 P24941 1/20 0.40
GAA P10253 2/20 0.39
PIN1 Q13526 2/20 0.39
CA1 P00915 1/20 0.39
CA9 Q16790 1/20 0.39
ROCK2 O75116 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
NAMPT P43490 1/20 0.37
MAPK1 P28482 2/20 0.37
RPS6KA5 O75582 1/20 0.37
RPS6KA4 O75676 1/20 0.37
PRKACA P17612 1/20 0.37
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
IRAK1 P51617 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4891405 1.00 AKT1 (0.41) AKT1ALDH1A1TSHRCDK2GAA
SCHEMBL4781246 1.00 AKT1 (0.41) AKT1ALDH1A1TSHRCDK2GAA
SCHEMBL4900162 0.97 AKT1 (0.41) AKT1ALDH1A1TSHRCDK2CA1
SCHEMBL4899142 0.97 AKT1 (0.41) AKT1ALDH1A1TSHRCDK2CA1
SCHEMBL4903498 0.95 ALDH1A1 (0.42) AKT1ALDH1A1CDK2GAANAMPT
SCHEMBL4901986 0.95 ALDH1A1 (0.42) AKT1ALDH1A1CDK2GAANAMPT
SCHEMBL4901998 0.93 AKT1 (0.41) AKT1ALDH1A1CDK2GAAPIN1
SCHEMBL4899055 0.93 GAA (0.41) AKT1ALDH1A1GAAROCK2HDAC3
SCHEMBL4904361 0.93 AKT1 (0.41) AKT1ALDH1A1CDK2GAAPIN1
SCHEMBL4899543 0.92 AKT1 (0.40) AKT1ALDH1A1TSHRCDK2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith D SIDOCKY NEIL R 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith JAK2, CHEK2, MTOR AKT1 26/4885ALDH1A1 1752/4885TSHR 2398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.